Filing metadata

Accession number
0001610717-24-000457
Form type
Form 4
Filer
Neumora Therapeutics, Inc.
CIK
CIK 1885522
Filed
Aug 27, 2024
Reporting period
Aug 27, 2024
Description
Insider transaction

Explore SEC Filings Hub